168 related articles for article (PubMed ID: 10374765)
1. The role of p21ras in pancreatic neoplasia and chronic pancreatitis.
Mulligan NJ; Yang S; Andry C; Klein M; O'Brien MJ
Hum Pathol; 1999 Jun; 30(6):602-10. PubMed ID: 10374765
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas.
Z'graggen K; Rivera JA; Compton CC; Pins M; Werner J; Fernández-del Castillo C; Rattner DW; Lewandrowski KB; Rustgi AK; Warshaw AL
Ann Surg; 1997 Oct; 226(4):491-8; discussion 498-500. PubMed ID: 9351717
[TBL] [Abstract][Full Text] [Related]
4. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas.
Izawa T; Obara T; Tanno S; Mizukami Y; Yanagawa N; Kohgo Y
Cancer; 2001 Oct; 92(7):1807-17. PubMed ID: 11745253
[TBL] [Abstract][Full Text] [Related]
5. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
[TBL] [Abstract][Full Text] [Related]
6. Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas.
Kitago M; Ueda M; Aiura K; Suzuki K; Hoshimoto S; Takahashi S; Mukai M; Kitajima M
Int J Cancer; 2004 Jun; 110(2):177-82. PubMed ID: 15069678
[TBL] [Abstract][Full Text] [Related]
7. Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas.
Kondo H; Sugano K; Fukayama N; Hosokawa K; Ohkura H; Ohtsu A; Mukai K; Yoshida S
Cancer; 1997 Mar; 79(5):900-5. PubMed ID: 9041151
[TBL] [Abstract][Full Text] [Related]
8. High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters.
Sugio K; Gazdar AF; Albores-Saavedra J; Kokkinakis DM
Carcinogenesis; 1996 Feb; 17(2):303-9. PubMed ID: 8625455
[TBL] [Abstract][Full Text] [Related]
9. Determination of pancreatic ductal carcinoma histogenesis by analysis of mucous quality and K-ras mutation.
Matsubayashi H; Watanabe H; Nishikura K; Ajioka Y; Kijima H; Saito T
Cancer; 1998 Feb; 82(4):651-60. PubMed ID: 9477096
[TBL] [Abstract][Full Text] [Related]
10. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients.
Sessa F; Solcia E; Capella C; Bonato M; Scarpa A; Zamboni G; Pellegata NS; Ranzani GN; Rickaert F; Klöppel G
Virchows Arch; 1994; 425(4):357-67. PubMed ID: 7820300
[TBL] [Abstract][Full Text] [Related]
11. Ki-ras codon 12 point mutation and p53 mutation in pancreatic diseases.
Yamaguchi K; Chijiiwa K; Noshiro H; Torata N; Kinoshita M; Tanaka M
Hepatogastroenterology; 1999; 46(28):2575-81. PubMed ID: 10522044
[TBL] [Abstract][Full Text] [Related]
12. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
[TBL] [Abstract][Full Text] [Related]
13. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
[TBL] [Abstract][Full Text] [Related]
14. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis.
Löhr M; Klöppel G; Maisonneuve P; Lowenfels AB; Lüttges J
Neoplasia; 2005 Jan; 7(1):17-23. PubMed ID: 15720814
[TBL] [Abstract][Full Text] [Related]
15. Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas.
Raimondo M; Tachibana I; Urrutia R; Burgart LJ; DiMagno EP
Am J Gastroenterol; 2002 Oct; 97(10):2553-8. PubMed ID: 12385438
[TBL] [Abstract][Full Text] [Related]
16. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma.
Kondo H; Sugano K; Fukayama N; Kyogoku A; Nose H; Shimada K; Ohkura H; Ohtsu A; Yoshida S; Shimosato Y
Cancer; 1994 Mar; 73(6):1589-94. PubMed ID: 8156485
[TBL] [Abstract][Full Text] [Related]
17. Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status.
Berger DH; Chang H; Wood M; Huang L; Heath CW; Lehman T; Ruggeri BA
Cancer; 1999 Jan; 85(2):326-32. PubMed ID: 10023699
[TBL] [Abstract][Full Text] [Related]
18. Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53.
Lüttges J; Diederichs A; Menke MA; Vogel I; Kremer B; Klöppel G
Cancer; 2000 Jun; 88(11):2495-504. PubMed ID: 10861425
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
20. Different amounts of K-ras mutant epithelial cells in pancreatic carcinoma and mass-forming pancreatitis.
Matsubayashi H; Watanabe H; Ajioka Y; Nishikura K; Yamano M; Seki T; Saito T; Matsubayashi T
Pancreas; 2000 Jul; 21(1):77-85. PubMed ID: 10881936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]